Dongfang Liu - 15 Jul 2022 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief Medical Officer
Signature
Dongfang Liu, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
15 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 17:21:09 UTC
Next filing
31 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +490,000 $0.000000 490,000 15 Jul 2022 Common Stock 490,000 $3.61 Direct F1
transaction NUVB Stock Option (Right to Buy) Award $0 +292,500 $0.000000 292,500 15 Jul 2022 Common Stock 292,500 $3.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
F2 The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.